DrugPatentWatch Database Preview
Mylan Ireland Ltd Company Profile
What is the competitive landscape for MYLAN IRELAND LTD, and when can generic versions of MYLAN IRELAND LTD drugs launch?
MYLAN IRELAND LTD has nine approved drugs.
There are ten US patents protecting MYLAN IRELAND LTD drugs.
There are thirty-three patent family members on MYLAN IRELAND LTD drugs in twenty-six countries and one supplementary protection certificate in one country.
Summary for Mylan Ireland Ltd
| International Patents: | 33 |
| US Patents: | 10 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 9 |
Drugs and US Patents for Mylan Ireland Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | 7,521,041 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | 7,550,595 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Mylan Ireland Ltd | ARIXTRA | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 021345-002 | May 28, 2004 | AP | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mylan Ireland Ltd | CARBAMAZEPINE | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 076697-001 | May 20, 2011 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | 7,585,879 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Mylan Ireland Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Ireland Ltd | ARIXTRA | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 021345-001 | Dec 7, 2001 | 4,818,816 | ➤ Try a Free Trial |
| Mylan Ireland Ltd | MIACALCIN | calcitonin salmon | SPRAY, METERED;NASAL | 020313-002 | Aug 17, 1995 | 5,733,569 | ➤ Try a Free Trial |
| Mylan Ireland Ltd | MIACALCIN | calcitonin salmon | SPRAY, METERED;NASAL | 020313-002 | Aug 17, 1995 | 5,759,565 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Mylan Ireland Ltd Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1930323 | ➤ Try a Free Trial |
| Japan | 2008532922 | ➤ Try a Free Trial |
| Spain | 2345640 | ➤ Try a Free Trial |
| Canada | 2557479 | ➤ Try a Free Trial |
| Japan | 4837653 | ➤ Try a Free Trial |
| Argentina | 048032 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Mylan Ireland Ltd Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 02C/012 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: FONDAPARINUX SODIQUE; REGISTRATION NO/DATE: EU/1/02/206/001 20020321 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
